The global OTC Vitamin and Dietary Supplement market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for OTC Vitamin and Dietary Supplement is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for OTC Vitamin and Dietary Supplement is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of OTC Vitamin and Dietary Supplement include Koninklijke DSM N.V., Reckitt Benckiser, Otsuka Holdings, CSPC Pharmaceutical Group Limited, Sanofi S.A., Atrium Innovations, DuPont, Bactolac Pharmaceutical and Dil Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for OTC Vitamin and Dietary Supplement, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Vitamin and Dietary Supplement.
Report Scope
The OTC Vitamin and Dietary Supplement market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Vitamin and Dietary Supplement market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Vitamin and Dietary Supplement manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Koninklijke DSM N.V.
Reckitt Benckiser
Otsuka Holdings
CSPC Pharmaceutical Group Limited
Sanofi S.A.
Atrium Innovations
DuPont
Bactolac Pharmaceutical
Dil Limited
GlaxoSmithKline
Pfizer
Lonza Group
Segment by Type
Liquid Supplements
Powder Supplements
Tablet Supplements
Capsule Supplements
Segment by Application
Hospitals
Pharmacies
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Vitamin and Dietary Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Vitamin and Dietary Supplement in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 OTC Vitamin and Dietary Supplement 麻豆原创 Overview
1.1 Product Overview and Scope of OTC Vitamin and Dietary Supplement
1.2 OTC Vitamin and Dietary Supplement Segment by Type
1.2.1 Global OTC Vitamin and Dietary Supplement 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Liquid Supplements
1.2.3 Powder Supplements
1.2.4 Tablet Supplements
1.2.5 Capsule Supplements
1.3 OTC Vitamin and Dietary Supplement Segment by Application
1.3.1 Global OTC Vitamin and Dietary Supplement 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Others
1.4 Global OTC Vitamin and Dietary Supplement 麻豆原创 Size Estimates and Forecasts
1.4.1 Global OTC Vitamin and Dietary Supplement Revenue 2019-2030
1.4.2 Global OTC Vitamin and Dietary Supplement Sales 2019-2030
1.4.3 Global OTC Vitamin and Dietary Supplement 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 OTC Vitamin and Dietary Supplement 麻豆原创 Competition by Manufacturers
2.1 Global OTC Vitamin and Dietary Supplement Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global OTC Vitamin and Dietary Supplement Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global OTC Vitamin and Dietary Supplement Average Price by Manufacturers (2019-2024)
2.4 Global OTC Vitamin and Dietary Supplement Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OTC Vitamin and Dietary Supplement, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Vitamin and Dietary Supplement, Product Type & Application
2.7 OTC Vitamin and Dietary Supplement 麻豆原创 Competitive Situation and Trends
2.7.1 OTC Vitamin and Dietary Supplement 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest OTC Vitamin and Dietary Supplement Players 麻豆原创 Share by Revenue
2.7.3 Global OTC Vitamin and Dietary Supplement 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OTC Vitamin and Dietary Supplement Retrospective 麻豆原创 Scenario by Region
3.1 Global OTC Vitamin and Dietary Supplement 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global OTC Vitamin and Dietary Supplement Global OTC Vitamin and Dietary Supplement Sales by Region: 2019-2030
3.2.1 Global OTC Vitamin and Dietary Supplement Sales by Region: 2019-2024
3.2.2 Global OTC Vitamin and Dietary Supplement Sales by Region: 2025-2030
3.3 Global OTC Vitamin and Dietary Supplement Global OTC Vitamin and Dietary Supplement Revenue by Region: 2019-2030
3.3.1 Global OTC Vitamin and Dietary Supplement Revenue by Region: 2019-2024
3.3.2 Global OTC Vitamin and Dietary Supplement Revenue by Region: 2025-2030
3.4 North America OTC Vitamin and Dietary Supplement 麻豆原创 Facts & Figures by Country
3.4.1 North America OTC Vitamin and Dietary Supplement 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America OTC Vitamin and Dietary Supplement Sales by Country (2019-2030)
3.4.3 North America OTC Vitamin and Dietary Supplement Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Vitamin and Dietary Supplement 麻豆原创 Facts & Figures by Country
3.5.1 Europe OTC Vitamin and Dietary Supplement 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe OTC Vitamin and Dietary Supplement Sales by Country (2019-2030)
3.5.3 Europe OTC Vitamin and Dietary Supplement Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Vitamin and Dietary Supplement 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific OTC Vitamin and Dietary Supplement 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific OTC Vitamin and Dietary Supplement Sales by Country (2019-2030)
3.6.3 Asia Pacific OTC Vitamin and Dietary Supplement Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America OTC Vitamin and Dietary Supplement 麻豆原创 Facts & Figures by Country
3.7.1 Latin America OTC Vitamin and Dietary Supplement 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America OTC Vitamin and Dietary Supplement Sales by Country (2019-2030)
3.7.3 Latin America OTC Vitamin and Dietary Supplement Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Vitamin and Dietary Supplement 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa OTC Vitamin and Dietary Supplement 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa OTC Vitamin and Dietary Supplement Sales by Country (2019-2030)
3.8.3 Middle East and Africa OTC Vitamin and Dietary Supplement Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Vitamin and Dietary Supplement Sales by Type (2019-2030)
4.1.1 Global OTC Vitamin and Dietary Supplement Sales by Type (2019-2024)
4.1.2 Global OTC Vitamin and Dietary Supplement Sales by Type (2025-2030)
4.1.3 Global OTC Vitamin and Dietary Supplement Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global OTC Vitamin and Dietary Supplement Revenue by Type (2019-2030)
4.2.1 Global OTC Vitamin and Dietary Supplement Revenue by Type (2019-2024)
4.2.2 Global OTC Vitamin and Dietary Supplement Revenue by Type (2025-2030)
4.2.3 Global OTC Vitamin and Dietary Supplement Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global OTC Vitamin and Dietary Supplement Price by Type (2019-2030)
5 Segment by Application
5.1 Global OTC Vitamin and Dietary Supplement Sales by Application (2019-2030)
5.1.1 Global OTC Vitamin and Dietary Supplement Sales by Application (2019-2024)
5.1.2 Global OTC Vitamin and Dietary Supplement Sales by Application (2025-2030)
5.1.3 Global OTC Vitamin and Dietary Supplement Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global OTC Vitamin and Dietary Supplement Revenue by Application (2019-2030)
5.2.1 Global OTC Vitamin and Dietary Supplement Revenue by Application (2019-2024)
5.2.2 Global OTC Vitamin and Dietary Supplement Revenue by Application (2025-2030)
5.2.3 Global OTC Vitamin and Dietary Supplement Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global OTC Vitamin and Dietary Supplement Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Koninklijke DSM N.V.
6.1.1 Koninklijke DSM N.V. Corporation Information
6.1.2 Koninklijke DSM N.V. Description and Business Overview
6.1.3 Koninklijke DSM N.V. OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Koninklijke DSM N.V. OTC Vitamin and Dietary Supplement Product Portfolio
6.1.5 Koninklijke DSM N.V. Recent Developments/Updates
6.2 Reckitt Benckiser
6.2.1 Reckitt Benckiser Corporation Information
6.2.2 Reckitt Benckiser Description and Business Overview
6.2.3 Reckitt Benckiser OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Reckitt Benckiser OTC Vitamin and Dietary Supplement Product Portfolio
6.2.5 Reckitt Benckiser Recent Developments/Updates
6.3 Otsuka Holdings
6.3.1 Otsuka Holdings Corporation Information
6.3.2 Otsuka Holdings Description and Business Overview
6.3.3 Otsuka Holdings OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Otsuka Holdings OTC Vitamin and Dietary Supplement Product Portfolio
6.3.5 Otsuka Holdings Recent Developments/Updates
6.4 CSPC Pharmaceutical Group Limited
6.4.1 CSPC Pharmaceutical Group Limited Corporation Information
6.4.2 CSPC Pharmaceutical Group Limited Description and Business Overview
6.4.3 CSPC Pharmaceutical Group Limited OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSPC Pharmaceutical Group Limited OTC Vitamin and Dietary Supplement Product Portfolio
6.4.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
6.5 Sanofi S.A.
6.5.1 Sanofi S.A. Corporation Information
6.5.2 Sanofi S.A. Description and Business Overview
6.5.3 Sanofi S.A. OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi S.A. OTC Vitamin and Dietary Supplement Product Portfolio
6.5.5 Sanofi S.A. Recent Developments/Updates
6.6 Atrium Innovations
6.6.1 Atrium Innovations Corporation Information
6.6.2 Atrium Innovations Description and Business Overview
6.6.3 Atrium Innovations OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Atrium Innovations OTC Vitamin and Dietary Supplement Product Portfolio
6.6.5 Atrium Innovations Recent Developments/Updates
6.7 DuPont
6.6.1 DuPont Corporation Information
6.6.2 DuPont Description and Business Overview
6.6.3 DuPont OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DuPont OTC Vitamin and Dietary Supplement Product Portfolio
6.7.5 DuPont Recent Developments/Updates
6.8 Bactolac Pharmaceutical
6.8.1 Bactolac Pharmaceutical Corporation Information
6.8.2 Bactolac Pharmaceutical Description and Business Overview
6.8.3 Bactolac Pharmaceutical OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bactolac Pharmaceutical OTC Vitamin and Dietary Supplement Product Portfolio
6.8.5 Bactolac Pharmaceutical Recent Developments/Updates
6.9 Dil Limited
6.9.1 Dil Limited Corporation Information
6.9.2 Dil Limited Description and Business Overview
6.9.3 Dil Limited OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dil Limited OTC Vitamin and Dietary Supplement Product Portfolio
6.9.5 Dil Limited Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GlaxoSmithKline OTC Vitamin and Dietary Supplement Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer OTC Vitamin and Dietary Supplement Description and Business Overview
6.11.3 Pfizer OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer OTC Vitamin and Dietary Supplement Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Lonza Group
6.12.1 Lonza Group Corporation Information
6.12.2 Lonza Group OTC Vitamin and Dietary Supplement Description and Business Overview
6.12.3 Lonza Group OTC Vitamin and Dietary Supplement Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Lonza Group OTC Vitamin and Dietary Supplement Product Portfolio
6.12.5 Lonza Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Vitamin and Dietary Supplement Industry Chain Analysis
7.2 OTC Vitamin and Dietary Supplement Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Vitamin and Dietary Supplement Production Mode & Process
7.4 OTC Vitamin and Dietary Supplement Sales and 麻豆原创ing
7.4.1 OTC Vitamin and Dietary Supplement Sales Channels
7.4.2 OTC Vitamin and Dietary Supplement Distributors
7.5 OTC Vitamin and Dietary Supplement Customers
8 OTC Vitamin and Dietary Supplement 麻豆原创 Dynamics
8.1 OTC Vitamin and Dietary Supplement Industry Trends
8.2 OTC Vitamin and Dietary Supplement 麻豆原创 Drivers
8.3 OTC Vitamin and Dietary Supplement 麻豆原创 Challenges
8.4 OTC Vitamin and Dietary Supplement 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Koninklijke DSM N.V.
Reckitt Benckiser
Otsuka Holdings
CSPC Pharmaceutical Group Limited
Sanofi S.A.
Atrium Innovations
DuPont
Bactolac Pharmaceutical
Dil Limited
GlaxoSmithKline
Pfizer
Lonza Group
听
听
*If Applicable.